๐Ÿ”Ž Trials Near Me

Home โ€บ Bleeding

Bleeding clinical trials recruiting in the U.S.

42 studies for Bleeding are recruiting participants at sites across the United States.

Bleeding is the loss of blood, inside or outside the body. A hemorrhage is severe bleeding. Learn about the causes of bleeding and how to treat it.

Cities with the most studies

By state

Recently updated studies

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 29, 2026 ยท NCT07410117

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

RecruitingPhase 2
Ages 18 to 90 ยท All sexes ยท Updated Sep 29, 2026 ยท NCT05958342

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07175428

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07626411

Delivering tAN to Reduce HMB: The LUNA Study

Recruiting
Ages 14 to 45 ยท Women ยท Updated Sep 28, 2026 ยท NCT07326722

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

RecruitingPhase 3
Ages 1 to 17 ยท Men ยท Updated Sep 23, 2026 ยท NCT05611801

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

RecruitingPhase 4
Ages 22 and older ยท All sexes ยท Updated Sep 23, 2026 ยท NCT06953726

Onyxโ„ข Liquid Embolic IDE Clinical Study

Recruiting
Ages 22 and older ยท All sexes ยท Updated Sep 21, 2026 ยท NCT06742801

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 18, 2026 ยท NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 9, 2026 ยท NCT06948318

Oil Pulling Reduction

Recruiting
Ages 18 to 70 ยท All sexes ยท Updated Aug 24, 2026 ยท NCT07706647

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 ยท All sexes ยท Updated Aug 21, 2026 ยท NCT04278404

Oxytocin Pharmacokinetics and Pharmacodynamics

RecruitingPhase 2
Ages 18 to 50 ยท Women ยท Updated Aug 21, 2026 ยท NCT05488457

Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Jul 10, 2026 ยท NCT06582810

Auricular VNS Following Intracerebral Hemorrhage

Recruiting
Ages 18 and older ยท All sexes ยท Updated Jul 6, 2026 ยท NCT06799390

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Jul 2, 2026 ยท NCT04189471

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Jun 26, 2026 ยท NCT04045665

Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids

RecruitingObservational study
Ages 18 to 90 ยท All sexes ยท Updated Jun 17, 2026 ยท NCT06106269

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older ยท Women ยท Updated Jun 15, 2026 ยท NCT06820177

Prospective HemorrhoIdaL EmboliSation (PILES) Registry

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Jun 12, 2026 ยท NCT07635784

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

RecruitingPhase 2/3
Up to age 17 ยท All sexes ยท Updated Jun 8, 2026 ยท NCT04924322

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

RecruitingPhase 2
Ages 18 to 100 ยท All sexes ยท Updated May 28, 2026 ยท NCT06657924

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

RecruitingPhase 3
Ages 18 and older ยท Men ยท Updated May 27, 2026 ยท NCT05568719

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.